XML 21 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Operating Activities:      
Net loss $ (84,658) $ (20,802,376) $ (25,006,486)
Shares issued for services 28,035 892,300  
Finance (income) loss arising from change in terms of convertible notes (145,932) 20,165,406  
Increase in net liabilities for sale 445,611  
Increase (decrease) in accounts payable and accrued expenses 78,692 (321,158)  
Amortization of debt discount 17,768  
Loss from marketable securities 2,635  
Decrease in amounts due from related party (721,530)  
Increase in deferred revenues 50,000  
Increase (decrease) in accrued interest 8,227 (65,924)  
Increase in other receivables 28,674 12,122  
Net cash used in operating activities (66,559) (345,549)  
Investing Activities:      
Selling of marketable securities 14,607  
Net cash provided by investing activities 14,607  
Financing Activities:      
Proceeds from sale of common stock and warrants (net of issuance expenses) 1,575,072  
Exercise of options 63  
Issuance of Shares in respect of proceeds received during 2017 117,150  
Issuance of convertible note 100,000  
Net cash provided by financing activities 1,792,285  
Net (decrease) increase in cash (51,952) 1,446,736  
Cash and cash equivalents - beginning of period 499,919 2,959 2,959
Cash and cash equivalents - end of period 447,967 1,449,695 $ 499,919
Non-cash transactions:      
Conversion to shares of convertible loans 85,218  
Cancellation of preferred shares $ (150,000)